staceywhite, Author at European Medical Journal - Page 22 of 195

What’s Next for Respiratory Virus Vaccines?

This infographic breaks down the current vaccine modalities and explores the critical role mucosal immunity may play in future vaccine strategies…

Review of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress 2025

THIS SPRING, Vienna, Austria played host to a momentous gathering, welcoming over 15,000 attendees from across five continents for the 35th ESCMID Global Congress..

New Frontiers in Antimicrobial Stewardship

AT the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress 2025, Karin Thursky, Director of the National Centre for Antimicrobial Stewardship…

Tackling Tuberculosis: The Current Landscape and Future Directions

The presentation by Guy Thwaites, Director of the Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Vietnam, focused on the current state of tuberculosis…

Perampanel as Early Add-On

Leading neurologist discusses evidence from a real-world post hoc analysis of the PERMIT study supporting perampanel as early add-on…

Update on Tabelecleucel▼ Trial

Latest data from the global ALLELE study confirms the benefits of tabelecleucel cell therapy for transplant recipients who go on to develop a rare but often fatal blood cancer.

Review of the 51st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)

THE 51st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) was held this year in the vibrant city of…

NREM Sleep Homeostatic Plasticity Carries the Risk of Epileptic Transformation

Tconcepts of epilepsy in the light of contemporary brain research, and highlight the involvement of non-rapid eye movement (NREM)…

Minimal Residual Disease: Predicting Relapse in Myeloma

In the evolving landscape of haematologic cancers, the concept of minimal residual disease, also known as measurable residual disease…

Novel Therapies and Targets for Parkinson’s Disease

In this editorial, the authors highlight newly licensed medications for the symptomatic treatment of Parkinson’s disease (PD) and their…